News
The pharmaceutical industry's next billion-dollar blockbuster won't come from a lab alone—it will come from listening to ...
This partnership merges BioSkryb's single cell amplification and multi-omics chemistry with 1Cell.Ai's OncoIncytes platform, creating a groundbreaking ... a powerful synergy of visionary science ...
In our view, Carvana is well on its way to becoming a widely recognized, high-quality business ... background checks. In 2024, it acquired Sterling Check, the second-largest player, creating ...
At this time, all participants have been placed on mute to prevent background noise ... commercial and synergy initiatives this quarter. We believe we have a business model that can outperform ...
Zeneara positions itself as a unique, plant-based tinnitus supplement that introduces what it calls the "Mute Button ...
Peachtree Corners ? one of the nation's first smart cities powered by real-world connected infrastructure and 5G ? proudly opened the doors of the first Georgia Tech Atrium today, signaling an ...
I’m here mainly as the business team for some of our professional clients, but also partners as part of that topic, also. My initial background has been more towards pharma, but very much also ...
14d
MarketBeat on MSNOmnicom Group Earnings Transcript (NYSE:OMC)Presentation Operator Hello and welcome to the Omnicom First Quarter 2025 Earnings Call. All lines have been placed on-mute ...
This partnership merges BioSkryb's single cell amplification and multi-omics chemistry with 1Cell.Ai's OncoIncytes platform, creating a groundbreaking solution ... "This collaboration represents a ...
SPERA PHARMA is currently the world's only company in the pharmaceutical industry offering contract analytical services with ...
The XtaLAB Synergy-ED incorporates 3D ED/MicroED ... methods and analytical technologies. Through this partnership, Rigaku and SPERA PHARMA aim to provide robust support at the forefront of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results